Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-22 Purchase | 2022-06-24 4:27 pm | Scholar Rock Holding Corp | SRRK | Nashat Amir Director | 1,197,992 | $4.9 | $5,870,161 | 513,836 (Indirect Direct) | View |
| 2021-05-21 Sale | 2021-05-25 7:20 pm | Morphic Holding Inc. | MORF | Nashat Amir Director | 232,295 | $45.5 | $10,569,423 | 136,691 (Indirect) | View |
| 2020-09-18 Purchase | 2020-09-22 5:10 pm | Metacrine Inc. | MTCR | Nashat Amir Director 10% Owner | 230,000 | $13 | $2,990,000 | 178,942 (Indirect) | View |
| 2019-07-31 Sale | 2019-08-02 4:32 pm | FATE THERAPEUTICS INC | FATE | Nashat Amir Director | 62,005 | $22.53 | $1,397,066 | 11,034 (Indirect) | View |
| 2019-07-26 Sale | 2019-07-30 6:25 pm | FATE THERAPEUTICS INC | FATE | Nashat Amir Director | 118,333 | $22.51 | $2,663,115 | 11,635 (Indirect) | View |
| 2019-07-23 Sale | 2019-07-25 6:24 pm | FATE THERAPEUTICS INC | FATE | Nashat Amir Director | 81,899 | $22.51 | $1,843,151 | 12,781 (Indirect) | View |
| 2019-07-18 Sale | 2019-07-22 5:52 pm | FATE THERAPEUTICS INC | FATE | Nashat Amir Director | 71,166 | $22.52 | $1,602,506 | 13,574 (Indirect) | View |
| 2019-07-01 Purchase | 2019-07-01 7:19 pm | Morphic Holding Inc. | MORF | Nashat Amir Director | 125,000 | $15 | $1,875,000 | 151,879 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-27 Gift | 2023-12-29 4:40 pm | N/A N/A | Scholar Rock Holding Corp | SRRK | Nashat Amir Director | 21,333 | $0 | 2,274,080 (Direct) | View |
| 2023-12-13 Other | 2023-12-15 4:26 pm | N/A N/A | Scholar Rock Holding Corp | SRRK | Nashat Amir Director | 1,223,976 | $0 | 1,467,883 (Indirect) | View |
| 2023-11-20 Other | 2023-11-22 4:30 pm | N/A N/A | Scholar Rock Holding Corp | SRRK | Nashat Amir Director | 611,992 | $0 | 731,103 (Indirect) | View |
| 2023-06-28 Other | 2023-06-30 7:12 pm | N/A N/A | Morphic Holding Inc. | MORF | Nashat Amir Director | 101,080 | $0 | 232,313 (Indirect) | View |
| 2023-06-21 Option Award | 2023-06-22 7:20 pm | N/A 2033-06-21 | Scholar Rock Holding Corp | SRRK | Nashat Amir Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 7:04 pm | N/A 2033-05-31 | Morphic Holding Inc. | MORF | Nashat Amir Director | 12,535 | $0 | 12,535 (Direct) | View |
| 2022-05-18 Option Award | 2022-09-06 7:27 pm | N/A 2032-05-17 | Metacrine Inc. | MTCR | Nashat Amir Director 10% Owner | 16,500 | $0 | 16,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 7:00 pm | N/A 2032-06-07 | Morphic Holding Inc. | MORF | Nashat Amir Director | 17,550 | $0 | 17,550 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:08 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 4:34 pm | N/A 2032-05-26 | Scholar Rock Holding Corp | SRRK | Nashat Amir Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2021-06-16 Option Award(A) | 2022-04-29 4:17 pm | N/A 2031-06-16 | Morphic Holding Inc. | MORF | Nashat Amir Director | 9,910 | $0 | 9,910 (Direct) | View |
| 2021-11-17 Other | 2021-11-19 4:32 pm | N/A N/A | Scholar Rock Holding Corp | SRRK | Nashat Amir Director | 346,721 | $0 | 409,989 (Indirect) | View |
| 2021-06-16 Option Award | 2021-06-17 7:12 pm | N/A 2031-06-16 | Morphic Holding Inc. | MORF | Nashat Amir Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 5:29 pm | N/A 2031-06-07 | Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-01 4:11 pm | N/A 2031-05-27 | Scholar Rock Holding Corp | SRRK | Nashat Amir Director | 7,800 | $0 | 7,800 (Direct) | View |
| 2021-05-24 Option Award | 2021-05-25 7:03 pm | N/A 2031-05-23 | Metacrine Inc. | MTCR | Nashat Amir Director 10% Owner | 16,500 | $0 | 16,500 (Direct) | View |
| 2020-09-18 Conversion | 2020-09-22 5:10 pm | N/A N/A | Metacrine Inc. | MTCR | Nashat Amir Director 10% Owner | 2,664,258 | $0 | 178,942 (Indirect) | View |
Ownership | 2020-09-15 5:11 pm | N/A N/A | Metacrine Inc. | MTCR | Nashat Amir Director 10% Owner | 0 | $0 | 2,664,258 (Indirect) | View |
| 2020-06-18 Option Award | 2020-06-19 6:20 pm | N/A 2030-06-18 | Morphic Holding Inc. | MORF | Nashat Amir Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 4:24 pm | N/A 2030-06-16 | Scholar Rock Holding Corp | SRRK | Nashat Amir Director 10% Owner | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-11 4:52 pm | N/A 2030-06-10 | Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2019-07-01 Conversion | 2019-07-01 7:19 pm | N/A N/A | Morphic Holding Inc. | MORF | Nashat Amir Director | 2,197,946 | $0 | 151,879 (Indirect) | View |
Ownership | 2019-06-26 9:25 pm | N/A N/A | Morphic Holding Inc. | MORF | Nashat Amir Director | 0 | $0 | 2,221,946 (Direct) | View |
| 2019-06-14 Option Award | 2019-06-18 4:21 pm | N/A 2029-06-13 | SELECTA BIOSCIENCES INC | SELB | Nashat Amir Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2019-06-11 Option Award | 2019-06-12 4:15 pm | N/A 2029-06-10 | Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director | 11,000 | $0 | 11,000 (Direct) | View |
| 2019-05-21 Option Award | 2019-05-23 9:41 pm | N/A 2029-05-21 | Scholar Rock Holding Corp | SRRK | Nashat Amir Director 10% Owner | 10,158 | $0 | 10,158 (Direct) | View |
| 2019-05-03 Option Award | 2019-05-07 4:06 pm | N/A 2029-05-03 | FATE THERAPEUTICS INC | FATE | Nashat Amir Director | 16,000 | $0 | 16,000 (Direct) | View |